• 4D Molecular Therapeutics' (FDMT) "Sell (D-)" Rating Reaffirmed at Weiss Ratings

    المصدر: Buzz FX / 20 يناير 2025 17:55:17   America/Chicago


    4D Molecular Therapeutics' (FDMT) "Sell (D-)" Rating Reaffirmed at Weiss Ratings Written by MarketBeat January 20, 2025 Share Link copied to clipboard. 4D Molecular Therapeutics ( NASDAQ:FDMT - Get Free Report ) 's stock had its "sell (d-)"
    Read more...
شارك على،